Cargando…

The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice

BACKGROUND: We previously showed that 1-methylnicotinamide (1-MNA) and its analog 1,4-dimethylpyridine (1,4-DMP) could inhibit the formation of lung metastases and enhance the efficacy of cyclophosphamide-based chemotherapy in the model of spontaneously metastasizing 4T1 mouse mammary gland tumors....

Descripción completa

Detalles Bibliográficos
Autores principales: Denslow, Agnieszka, Switalska, Marta, Nowak, Marcin, Maciejewska, Magdalena, Chlopicki, Stefan, Marcinek, Andrzej, Gebicki, Jerzy, Wietrzyk, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341170/
https://www.ncbi.nlm.nih.gov/pubmed/28270133
http://dx.doi.org/10.1186/s12885-017-3161-4
_version_ 1782512943035842560
author Denslow, Agnieszka
Switalska, Marta
Nowak, Marcin
Maciejewska, Magdalena
Chlopicki, Stefan
Marcinek, Andrzej
Gebicki, Jerzy
Wietrzyk, Joanna
author_facet Denslow, Agnieszka
Switalska, Marta
Nowak, Marcin
Maciejewska, Magdalena
Chlopicki, Stefan
Marcinek, Andrzej
Gebicki, Jerzy
Wietrzyk, Joanna
author_sort Denslow, Agnieszka
collection PubMed
description BACKGROUND: We previously showed that 1-methylnicotinamide (1-MNA) and its analog 1,4-dimethylpyridine (1,4-DMP) could inhibit the formation of lung metastases and enhance the efficacy of cyclophosphamide-based chemotherapy in the model of spontaneously metastasizing 4T1 mouse mammary gland tumors. In the present study, we aimed to investigate whether the previously observed activity of pyridine compounds pertains also to the prevention and the treatment of metastatic prostate tumors, in a combined chemotherapy with docetaxel. METHODS: Cancer-preventing activity of 1,4-DMP was studied in the model of prostate tumors spontaneously arising in C57BL/6-Tg (TRAMP)8247Ng/J (TRAMP) mice. The efficacy of the combined chemotherapy, comprising simultaneous use of 1,4-DMP and docetaxel, was evaluated in the orthotopic mouse model of human PC-3M-luc2 prostate cancer. The toxicity of the applied treatment was also determined. RESULTS: The development of prostate tumors in TRAMP mice remained unaffected after administration of 1,4-DMP. Similarly, no effect of 1,4-DMP was found on the growth of orthotopically transplanted PC-3M-luc2 tumors. However, when 1,4-DMP was administered along with docetaxel, it enhanced the anticancer activity of the chemotherapy. As a result, in PC-3M-luc2-bearing mice statistically significant inhibition of the tumor growth and lower metastases incidence were observed. The decreased metastatic yield is probably related to the diminished platelet activity observed in mice treated with combined therapeutic regimen. Finally, the combined treatment exhibited lowered side effects accompanying docetaxel administration. CONCLUSIONS: Results presented herein confirm previously published data on the anticancer activity of pyridine compounds and demonstrate that 1,4-DMP may be beneficially implemented into chemotherapy utilizing various cytotoxic agents, directed against multiple metastatic tumor types. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3161-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5341170
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53411702017-03-10 The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice Denslow, Agnieszka Switalska, Marta Nowak, Marcin Maciejewska, Magdalena Chlopicki, Stefan Marcinek, Andrzej Gebicki, Jerzy Wietrzyk, Joanna BMC Cancer Research Article BACKGROUND: We previously showed that 1-methylnicotinamide (1-MNA) and its analog 1,4-dimethylpyridine (1,4-DMP) could inhibit the formation of lung metastases and enhance the efficacy of cyclophosphamide-based chemotherapy in the model of spontaneously metastasizing 4T1 mouse mammary gland tumors. In the present study, we aimed to investigate whether the previously observed activity of pyridine compounds pertains also to the prevention and the treatment of metastatic prostate tumors, in a combined chemotherapy with docetaxel. METHODS: Cancer-preventing activity of 1,4-DMP was studied in the model of prostate tumors spontaneously arising in C57BL/6-Tg (TRAMP)8247Ng/J (TRAMP) mice. The efficacy of the combined chemotherapy, comprising simultaneous use of 1,4-DMP and docetaxel, was evaluated in the orthotopic mouse model of human PC-3M-luc2 prostate cancer. The toxicity of the applied treatment was also determined. RESULTS: The development of prostate tumors in TRAMP mice remained unaffected after administration of 1,4-DMP. Similarly, no effect of 1,4-DMP was found on the growth of orthotopically transplanted PC-3M-luc2 tumors. However, when 1,4-DMP was administered along with docetaxel, it enhanced the anticancer activity of the chemotherapy. As a result, in PC-3M-luc2-bearing mice statistically significant inhibition of the tumor growth and lower metastases incidence were observed. The decreased metastatic yield is probably related to the diminished platelet activity observed in mice treated with combined therapeutic regimen. Finally, the combined treatment exhibited lowered side effects accompanying docetaxel administration. CONCLUSIONS: Results presented herein confirm previously published data on the anticancer activity of pyridine compounds and demonstrate that 1,4-DMP may be beneficially implemented into chemotherapy utilizing various cytotoxic agents, directed against multiple metastatic tumor types. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3161-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-07 /pmc/articles/PMC5341170/ /pubmed/28270133 http://dx.doi.org/10.1186/s12885-017-3161-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Denslow, Agnieszka
Switalska, Marta
Nowak, Marcin
Maciejewska, Magdalena
Chlopicki, Stefan
Marcinek, Andrzej
Gebicki, Jerzy
Wietrzyk, Joanna
The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
title The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
title_full The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
title_fullStr The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
title_full_unstemmed The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
title_short The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
title_sort effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341170/
https://www.ncbi.nlm.nih.gov/pubmed/28270133
http://dx.doi.org/10.1186/s12885-017-3161-4
work_keys_str_mv AT denslowagnieszka theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT switalskamarta theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT nowakmarcin theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT maciejewskamagdalena theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT chlopickistefan theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT marcinekandrzej theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT gebickijerzy theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT wietrzykjoanna theeffectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT denslowagnieszka effectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT switalskamarta effectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT nowakmarcin effectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT maciejewskamagdalena effectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT chlopickistefan effectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT marcinekandrzej effectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT gebickijerzy effectsof14dimethylpyridineinmetastaticprostatecancerinmice
AT wietrzykjoanna effectsof14dimethylpyridineinmetastaticprostatecancerinmice